Literature DB >> 7765351

Taxol: the chemistry and structure-activity relationships of a novel anticancer agent.

D G Kingston1.   

Abstract

Taxol is an exciting new anticancer drug, showing clinical activity against ovarian and breast cancer. Its development as a clinically useful drug has involved major efforts to overcome the supply problem; this has now been done, and the focus of interest has moved to the development of improved analogs of the drug. Recent notable achievements include the first total synthesis of taxol, and the first indications of its binding site on tubulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7765351     DOI: 10.1016/0167-7799(94)90120-1

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  21 in total

Review 1.  Plant tubulins: a melting pot for basic questions and promising applications.

Authors:  D Breviario; P Nick
Journal:  Transgenic Res       Date:  2000-12       Impact factor: 2.788

2.  Engineering a Carotenoid-Overproducing Strain of Azospirillum brasilense for Heterologous Production of Geraniol and Amorphadiene.

Authors:  Shivangi Mishra; Parul Pandey; Ashutosh Prakash Dubey; Aafreen Zehra; Chandan Singh Chanotiya; Anil Kumar Tripathi; Mukti Nath Mishra
Journal:  Appl Environ Microbiol       Date:  2020-08-18       Impact factor: 4.792

Review 3.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

4.  Bio-production of Baccatin III, an Important Precursor of Paclitaxel by a Cost-Effective Approach.

Authors:  Shu-Ling Lin; Tao Wei; Jun-Fang Lin; Li-Qiong Guo; Guang-Pei Wu; Jun-Bin Wei; Jia-Jun Huang; Ping-Lan Ouyang
Journal:  Mol Biotechnol       Date:  2018-07       Impact factor: 2.695

5.  Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.

Authors:  Feihu Wang; Michael Porter; Alexandros Konstantopoulos; Pengcheng Zhang; Honggang Cui
Journal:  J Control Release       Date:  2017-09-25       Impact factor: 9.776

6.  A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.

Authors:  P Giannakakou; R Gussio; E Nogales; K H Downing; D Zaharevitz; B Bollbuck; G Poy; D Sackett; K C Nicolaou; T Fojo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Structural intermediates in the assembly of taxoid-induced microtubules and GDP-tubulin double rings: time-resolved X-ray scattering.

Authors:  J F Diaz; J M Andreu; G Diakun; E Towns-Andrews; J Bordas
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

8.  Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of LPS for combined chemo-immunotherapy.

Authors:  Aniruddha Roy; Sourav Chandra; Swapna Mamilapally; Pramod Upadhyay; Sangeeta Bhaskar
Journal:  Pharm Res       Date:  2012-05-01       Impact factor: 4.200

9.  Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.

Authors:  Pritam Thapa; Mengjie Li; Moses Bio; Pallavi Rajaputra; Gregory Nkepang; Yajing Sun; Sukyung Woo; Youngjae You
Journal:  J Med Chem       Date:  2016-03-22       Impact factor: 7.446

10.  A serine carboxypeptidase-like acyltransferase is required for synthesis of antimicrobial compounds and disease resistance in oats.

Authors:  Sam T Mugford; Xiaoquan Qi; Saleha Bakht; Lionel Hill; Eva Wegel; Richard K Hughes; Kalliopi Papadopoulou; Rachel Melton; Mark Philo; Frank Sainsbury; George P Lomonossoff; Abhijeet Deb Roy; Rebecca J M Goss; Anne Osbourn
Journal:  Plant Cell       Date:  2009-08-14       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.